On January 3, 2018 Juno Therapeutics, Inc. (NASDAQ:JUNO) reported that it will webcast its presentation at the 36th Annual J.P. Morgan Healthcare Conference at 4:00 p.m. PT on Tuesday, January 9, 2018 (Press release, Juno, JAN 3, 2018, View Source [SID1234522883]). The presentation will feature a business overview and update by Hans Bishop, Juno’s President and Chief Executive Officer.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast will be accessible on the Investor Relations page of Juno’s website at www.JunoTherapeutics.com. A replay of the presentation will be available at the same location for 30 days following the conference.